Analysts have been eager to weigh in on the Healthcare sector with new ratings on 4D Molecular Therapeutics (FDMT – Research Report), Dynavax (DVAX – Research Report) and Natera (NTRA – Research Report).
4D Molecular Therapeutics (FDMT)
In a report issued on May 9, Salveen Richter from Goldman Sachs initiated coverage with a Buy rating on 4D Molecular Therapeutics and a price target of $81.00. The company’s shares closed last Tuesday at $25.94.
According to TipRanks.com, Richter is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for 4D Molecular Therapeutics with a $51.14 average price target, implying a 93.8% upside from current levels. In a report issued on May 9, RBC Capital also maintained a Buy rating on the stock with a $40.00 price target.
See today’s best-performing stocks on TipRanks >>
Dynavax (DVAX)
Goldman Sachs analyst Paul Choi maintained a Hold rating on Dynavax on May 9 and set a price target of $20.00. The company’s shares closed last Tuesday at $10.85, close to its 52-week low of $10.48.
According to TipRanks.com, Choi is a 4-star analyst with an average return of
Currently, the analyst consensus on Dynavax is a Strong Buy with an average price target of $25.75.
Natera (NTRA)
In a report issued on May 9, Matthew Sykes from Goldman Sachs maintained a Buy rating on Natera, with a price target of $114.00. The company’s shares closed last Tuesday at $105.74, close to its 52-week high of $108.32.
According to TipRanks.com, Sykes is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Natera with a $114.15 average price target, implying a 9.7% upside from current levels. In a report issued on May 9, Leerink Partners also maintained a Buy rating on the stock with a $130.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on FDMT:
